HLA HAPLOTYPES AS BIOMARKERS FOR COVID-19 SYMPTOM SEVERITY

    公开(公告)号:US20240018586A1

    公开(公告)日:2024-01-18

    申请号:US18039631

    申请日:2021-11-26

    Applicant: PXD Limited

    Inventor: David Langton

    Abstract: The present invention relates to methods, devices and kits for identifying individuals who are at increased risk of developing severe symptoms associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The present invention also relates to methods, devices and kits for identifying individuals who have a reduced risk of developing severe symptoms associated with SARS-CoV-2 infection. In particular, it relates to the use of HLA haplotypes as biomarkers to predict disease severity in individuals infected with SARS-CoV-2.

Patent Agency Ranking